UBS OCONNOR LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,836,945
-13.4%
134,412
+28.7%
0.05%
-31.3%
Q2 2023$2,120,608
+1.6%
104,412
-8.8%
0.07%
+4.7%
Q1 2023$2,088,115
-99.8%
114,480
+195.6%
0.06%
+236.8%
Q3 2022$1,013,000,000
-20.7%
38,725
-23.2%
0.02%0.0%
Q2 2022$1,278,000,00050,4250.02%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders